RBPJ inhibits the movability of endometrial carcinoma cells by miR-155/NF-κB/ROS pathway
Yufeng Xiao,1,* Xiaoli Wang,2,* Xiping Dong,3 Yan Zhang,1 Haibin Liu4 1Department of Gynecology, Chengwu People’s Hospital, Heze, Shandong Province 274700, People’s Republic of China; 2Department of Gynecology, Liangshan People’s Hospital, Jining, Shandong Province 2726...
Main Authors: | Xiao Y, Wang X, Dong X, Zhang Y, Liu H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/rbpj-inhibits-the-movability-of-endometrial-carcinoma-cells-by-mir-155-peer-reviewed-article-OTT |
Similar Items
-
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
by: Li Y, et al.
Published: (2018-03-01) -
Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma
by: Anukriti Singh, et al.
Published: (2020-10-01) -
Inhibition of Recombining Binding Protein Suppressor of Hairless (RBPJ) Impairs the Growth of Prostate Cancer
by: Li Xue, et al.
Published: (2015-07-01) -
Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway
by: Hanzi Xu, et al.
Published: (2018-07-01) -
SUMOylated non-canonical polycomb PRC1.6 complex as a prerequisite for recruitment of transcription factor RBPJ
by: Małgorzata Sotomska, et al.
Published: (2021-07-01)